BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26514676)

  • 1. Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.
    Yin J; Sheng B; Pu A; Han B; Yang K; Wang Q; Sun L; Yang H
    Dig Dis Sci; 2016 Feb; 61(2):444-52. PubMed ID: 26514676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AhR is involved in the regulation of LoVo cell proliferation through cell cycle-associated proteins.
    Yin J; Sheng B; Han B; Pu A; Yang K; Li P; Wang Q; Xiao W; Yang H
    Cell Biol Int; 2016 May; 40(5):560-8. PubMed ID: 26861731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells.
    Tomblin JK; Salisbury TB
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1092-6. PubMed ID: 24380854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AhR‑E2F1‑KGFR signaling is involved in KGF‑induced intestinal epithelial cell proliferation.
    Yang K; Yin J; Sheng B; Wang Q; Han B; Pu A; Yu M; Sun L; Xiao W; Yang H
    Mol Med Rep; 2017 May; 15(5):3019-3026. PubMed ID: 28339052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells.
    Han Z; Miwa Y; Obikane H; Mitsumata M; Takahashi-Yanaga F; Morimoto S; Sasaguri T
    Cardiovasc Res; 2008 Mar; 77(4):809-18. PubMed ID: 18065768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-3-carbinol induces tumor cell death: function follows form.
    Megna BW; Carney PR; Nukaya M; Geiger P; Kennedy GD
    J Surg Res; 2016 Jul; 204(1):47-54. PubMed ID: 27451867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
    Cheng YH; Li LA; Lin P; Cheng LC; Hung CH; Chang NW; Lin C
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):360-7. PubMed ID: 22820424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line.
    Mohammadi S; Seyedhosseini FS; Behnampour N; Yazdani Y
    J Recept Signal Transduct Res; 2017 Oct; 37(5):506-514. PubMed ID: 28812970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
    Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
    Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth.
    Yin XF; Chen J; Mao W; Wang YH; Chen MH
    J Exp Clin Cancer Res; 2012 May; 31(1):46. PubMed ID: 22592002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
    Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
    Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death.
    Wei KL; Chen FY; Lin CY; Gao GL; Kao WY; Yeh CH; Chen CR; Huang HC; Tsai WR; Jong KJ; Li WJ; Su JG
    Toxicol Appl Pharmacol; 2016 Sep; 306():86-97. PubMed ID: 27286660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
    Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
    Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line.
    Alhaider AA; El Gendy MA; Korashy HM; El-Kadi AO
    J Ethnopharmacol; 2011 Jan; 133(1):184-90. PubMed ID: 20883769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells.
    Faust D; Kletting S; Ueberham E; Dietrich C
    Toxicol Lett; 2013 Oct; 223(1):73-80. PubMed ID: 24013123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas.
    Chang JT; Chang H; Chen PH; Lin SL; Lin P
    Clin Cancer Res; 2007 Jan; 13(1):38-45. PubMed ID: 17200336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.